Global Pets Anti-infective Drugs Market Growth 2023-2029

Global Pets Anti-infective Drugs Market Growth 2023-2029

Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.
LPI (LP Information)' newest research report, the “Pets Anti-infective Drugs Industry Forecast” looks at past sales and reviews total world Pets Anti-infective Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Pets Anti-infective Drugs sales for 2023 through 2029. With Pets Anti-infective Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pets Anti-infective Drugs industry.
This Insight Report provides a comprehensive analysis of the global Pets Anti-infective Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pets Anti-infective Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pets Anti-infective Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pets Anti-infective Drugs and breaks down the forecast by administration method, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pets Anti-infective Drugs.
The global Pets Anti-infective Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
In the China market, core pets anti-infective drugs manufacturers include Zoetis, Merck and Elanco etc. The Top 3 companies hold a share above 40%.
This report presents a comprehensive overview, market shares, and growth opportunities of Pets Anti-infective Drugs market by product administration method, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by administration method
External Use
Internal Use
Injection
Segmentation by application
Dog
Cat
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook

Key Questions Addressed in this Report
What is the 10-year outlook for the global Pets Anti-infective Drugs market?
What factors are driving Pets Anti-infective Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pets Anti-infective Drugs market opportunities vary by end market size?
How does Pets Anti-infective Drugs break out administration method, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.